Clinical Trial Update: Developing Clinical Tools to Communicate Genetic Risk for Individuals Who Are Clinical High Risk for Psychosis [Phase 1]

View source ↗

Summary

Phase 1 clinical trial assessing tools to communicate genetic risk for individuals at clinical high risk for psychosis; completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psychosis

Snippet

Sponsor: New York University | Conditions: Psychosis | Phase 1 | Status: COMPLETED | Results posted: 2024-03-19